SGS, a clinical and bioanalytical contract solutions provider, said that the company will implement the Veeva Vault CTMS (clinical trial management system) across its network of clinical operations sites for the management of its global clinical study services.
 
Vault CTMS will enable SGS to share state-of-the-art reporting capabilities with its clients and deliver greater flexibility in running studies. Together with Veeva Vault eTMF (electronic trial master file), SGS will drive greater harmonization across its clinical operations. SGS will begin running studies on Vault CTMS in spring 2019, with any current studies scheduled to end after June 2019 being migrated to the new system.
 
“Veeva Vault CTMS, along with Veeva Vault eTMF will allow us to streamline our clinical trial management and improve decision-making within our planning and operations teams across the Americas and Europe,” saod Janelle Johnson, SGS International Project Management Director. “SGS is committed to investing where necessary to maintain its leadership position in clinical research, and ensuring it has the most efficient systems, and in-turn, offer the highest level of service and experience to our clients.”
 
“Veeva Vault CTMS will enable SGS’ to improve its operational efficiency and drive faster, higher-quality trial execution,” said Henry Galio, senior director, Veeva Vault CTMS. “Now clinicians and managers can have greater oversight and improved decision-making capabilities during studies.”
 
SGS North America is exhibiting at CPhI North America at stand 2636.